Critical Care

official impact factor 4.60

Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis

Anne CJM de Pont* and Marcus J Schultz

Critical Care 2009, 13:113 doi:10.1186/cc7684


See related research by Camporota et al., http://ccforum.com/content/12/6/R163

Accesses  

  • Last 30 days: 63 accesses
  • Last 365 days: 487 accesses
  • All time: 1737 accesses

Cited by